MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

NEOG

9.17

-1.5%↓

Search

Quanterix Corp

Închisă

SectorSănătate

7.14 -2.86

Rezumat

Modificarea prețului

24h

Curent

Minim

7.03

Maxim

7.42

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+1.9% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

106M

344M

Deschiderea anterioară

10

Închiderea anterioară

7.14

Sentimentul știrilor

By Acuity

75%

25%

337 / 361 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 ian. 2026, 19:05 UTC

Principalele dinamici ale pieței

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 ian. 2026, 23:41 UTC

Market Talk

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 ian. 2026, 23:41 UTC

Market Talk

Global Equities Roundup: Market Talk

13 ian. 2026, 23:33 UTC

Market Talk

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 ian. 2026, 23:13 UTC

Achiziții, Fuziuni, Preluări

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 ian. 2026, 23:10 UTC

Achiziții, Fuziuni, Preluări

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 ian. 2026, 23:03 UTC

Market Talk

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 ian. 2026, 21:50 UTC

Achiziții, Fuziuni, Preluări

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 ian. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

13 ian. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 ian. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 ian. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 ian. 2026, 21:15 UTC

Achiziții, Fuziuni, Preluări

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 ian. 2026, 21:08 UTC

Achiziții, Fuziuni, Preluări

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 ian. 2026, 20:39 UTC

Market Talk

Silver Settles at Another New High -- Market Talk

13 ian. 2026, 20:21 UTC

Market Talk

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 ian. 2026, 20:17 UTC

Market Talk

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 ian. 2026, 19:08 UTC

Achiziții, Fuziuni, Preluări

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 ian. 2026, 19:03 UTC

Câștiguri

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 ian. 2026, 18:50 UTC

Câștiguri

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 ian. 2026, 17:54 UTC

Market Talk

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 ian. 2026, 17:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

13 ian. 2026, 17:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 ian. 2026, 17:49 UTC

Market Talk

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 ian. 2026, 17:38 UTC

Market Talk

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 ian. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

13 ian. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 ian. 2026, 17:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

13 ian. 2026, 17:19 UTC

Market Talk

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 ian. 2026, 17:15 UTC

Market Talk

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

1.9% sus

Prognoză pe 12 luni

Medie 7.5 USD  1.9%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

337 / 361 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat